These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2057018)

  • 1. Depression of early protection against influenza virus infection by cyclophosphamide and its restoration by Y-19995 [2,4'-bis(1-methyl-2-dimethyl-aminoethoxyl)-3-benzoylpyridine dimaleate].
    Tsuru S; Shinomiya N; Nomoto K
    Nat Immun Cell Growth Regul; 1991; 10(1):1-11. PubMed ID: 2057018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of host defence by Y-19995 (2,4'-bis(1-methyl-2-dimethyl-aminoethoxyl)-3-benzoylpyridine dimaleate), a novel synthetic compound. I. Accelerated restoration from the leukocytopenia and augmented protection against microbial infections in immunocompromised mice.
    Fujisawa H; Tsuru S; Hisatome M; Goto K; Oe T; Okumoto T; Taniguchi M; Nomoto K
    J Clin Lab Immunol; 1987 Aug; 23(4):203-8. PubMed ID: 3312612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression of early protection against influenza virus infection by cyclophosphamide and its restoration by protein-bound polysaccharide.
    Tsuru S
    Kitasato Arch Exp Med; 1992 Sep; 65(2-3):97-110. PubMed ID: 1339197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of host defence by Y-19995 (2,4'-bis(1-methyl-2-dimethyl-aminoethoxyl)-3-benzoylpyridine dimaleate), a novel synthetic compound. II. Activation of phagocytic cell functions.
    Fujisawa H; Tsuru S; Taniguchi M; Nomoto K
    J Clin Lab Immunol; 1987 Dec; 24(4):177-81. PubMed ID: 3502347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.
    Iwasaki T; Nozima T
    J Immunol; 1977 Jan; 118(1):256-63. PubMed ID: 401512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection.
    Fujisawa H; Tsuru S; Taniguchi M; Zinnaka Y; Nomoto K
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():425-32. PubMed ID: 3819696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of protection during the early phase of a generalized viral infection. II. Contribution of polymorphonuclear leukocytes to protection against intravenous infection with influenza virus.
    Tsuru S; Fujisawa H; Taniguchi M; Zinnaka Y; Nomoto K
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():419-24. PubMed ID: 3819695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
    Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
    J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
    Lightman S; Cobbold S; Waldmann H; Askonas BA
    Immunology; 1987 Sep; 62(1):139-44. PubMed ID: 2820868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of recombinant human alpha interferon against influenza virus infection in mice.
    Sasaki O; Karaki T; Imanishi J
    Biken J; 1985 Dec; 28(3-4):79-82. PubMed ID: 3010939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of mice to reinfection after E-aminocaproic acid treatment of primary influenza virus infection.
    Lozitsky VP; Puzis LE; Polyak RYa
    Acta Virol; 1988 Mar; 32(2):117-22. PubMed ID: 2899958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
    Kris RM; Asofsky R; Evans CB; Small PA
    J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.
    Conti G; Magliani W; Conti S; Nencioni L; Sgarbanti R; Palamara AT; Polonelli L
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4331-7. PubMed ID: 18824612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon and humoral immune response in experimental influenza: infection with A/PR8 virus adapted to the mouse.
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):323-8. PubMed ID: 6160829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system.
    Yamada H; Nagai T
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):185-92. PubMed ID: 9646280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine regulation of the inflammatory response to a low-dose influenza infection in CCR2-/- mice.
    Wareing MD; Lyon A; Inglis C; Giannoni F; Charo I; Sarawar SR
    J Leukoc Biol; 2007 Mar; 81(3):793-801. PubMed ID: 17179466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study].
    Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
    J Cardiol; 2005 Jun; 45(6):247-55. PubMed ID: 15991608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.